CLDI
Calidi Biotherapeutics Inc.
NYSE MKT: CLDI · HEALTHCARE · BIOTECHNOLOGY
$0.22
+7.53% today
Updated 2026-04-30
Market cap
$2.46M
P/E ratio
—
P/S ratio
50.83x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$0 – $13
Volume
4.3M
Calidi Biotherapeutics Inc. (CLDI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $1.85M | $3.39M | $2.60M | $10.02M | $14.18M |
| Cash & equivalents | $420000.00 | $2.14M | $372000.00 | $2.05M | $9.59M |
| Current assets | $513000.00 | $2.74M | $786000.00 | $4.30M | $10.23M |
| Total liabilities | $24.33M | $26.00M | $53.04M | $18.25M | $12.21M |
| Current liabilities | $8.89M | $25.96M | $42.99M | $10.23M | $9.50M |
| Long-term debt | $6.37M | — | — | $2.06M | $600000.00 |
| Shareholder equity | $-22.48M | $-22.61M | $-50.44M | $-8.23M | $1.53M |
| Retained earnings | $-34.44M | $-44.93M | $-70.36M | $-99.57M | $-121.72M |
| Accounts receivable | — | — | $870.00 | $1.36M | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |